Rankings
▼
Calendar
TARS Q4 2019 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
TARS
Tarsus Pharmaceuticals, Inc.
$3B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-0.13
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$806,000
Free Cash Flow
-$830,000
Stock-Based Comp.
$5,000
Balance Sheet
Total Assets
$58M
Total Liabilities
$64M
Stockholders' Equity
-$6M
Cash & Equivalents
$58M
← FY 2019
All Quarters
Q1 2020 →
